[{"Assets_0_FY_USD":1404600000.0,"CIK":"899923","CommonStockSharesConverted_0_FY_shares":74700000.0,"CommonStockSharesOutstanding_0_FY_shares":74700000.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":-0.74,"EarningsPerShareBasic_4_FY_USD":-2.69,"EarningsPerShareDiluted_1_FY_USD":-0.74,"EarningsPerShareDiluted_4_FY_USD":-2.69,"Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":60700000.0,"NetIncomeLossConverted_1_FY_USD":-55400000.0,"NetIncomeLossConverted_4_FY_USD":-199500000.0,"OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_FY_USD":93200000.0,"RevenuesConverted_4_FY_USD":638600000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":918200000.0,"StockholdersEquity_0_FY_USD":918200000.0,"Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":74.6,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":74300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":74.6,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":74300000.0,"filed":"20200813","footnote":"nan","form":"10-K","fp":"FY","fy":"2020.0","name":"MYRIAD GENETICS INC","period":"20200630","qtrs":"4","uom":"USD"}]